에 대한 최신 뉴스 Trip.com Group (NASDAQ:TCOM) 주식

TRIP.COM GROUP LTD-ADR

Trip.com Group

Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from its online platform, but the company also maintains offline call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.

buildings-673087

News

BABA

TCOM

수요일(9일) 오후 도널드 트럼프 대통령이 미국의 무역 조치에 보복하지 않은 국가에 대한 추가 관세 90일 유예를 발표하면서 대형 중국 기업 주식을 추종하는 iShares China Large-Cap ETF(NASDAQ:FXI)가 반등했다.

중국 제외한 관세 유예 발표...알리바바, JD닷컴 및 대형 중국 주식 상황은?

MicroStrategy Incorporated (MSTR)

Equities

Large Cap

Movers

Trading Ideas

$BTC

ESLT

MRNA

MSTR

OKTA

지난주 가장 좋은 성과를 보인 대형주 10개는 다음과 같다.

옥타·모더나·스트레티지 등 지난주 급등한 대형주 10종목 (3월 3일~7일)

Inscription,Investment.,China,Flag,,With,The,Financial,Data,In,The

Opinion

FINV

많은 국가가 2025년까지 지출을 줄이려고 노력하고 있지만, 주목할 만한 국가 중 한 곳은 바로 중국이다. 중국 정부는 침체된 경제를 부양하기 위해 일련의 경기 부양책을 약속해 왔으며, 지난주 은행 부문에 550억 달러(4,000억 위안) 이상을 투입하겠다고 발표하면서 이러한 금전적 약속 중 하나가 이행되었다.알리바바 JD닷컴 핀볼루션 트립닷컴

중국의 대규모 부양책 속 매수할 만한 주식 4종목

Trip.com Group Limited - American Depositary Shares

Trip.com Group Ltd

When you find your dream home—whether it's the wraparound porch, the walk-in pantry, or just the feeling that it's finally yours—logic can take a backseat. Especially when you're 28 and standing on the <a href="https://www.benzinga.com/personal-finance/24/10/41528892/can-you-guess-the-real-price-of-achieving-the-american-dream-heres-a-hint-youll-need-way-more-th">edge of the American Dream</a> with a pen in one hand and a contract in the other.
That's where Stephanie found herself. She <a href="https://youtu.be/z-iypKuypTU?si=a0MCNQScIaYIdzDZ">called in to "The Ramsey Show</a>" from Arlington, Virginia, hoping for a thumbs-up from the personal finance legend himself. What she got instead? A very loud, very blunt: "You're too broke."
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a></li>
</ul>
Stephanie, who said she's been renting since graduating college, recently went under contract to buy a $760,000 home. Her plan? Use the sale of her employee stock to cover part of the down payment, then <a href="https://www.benzinga.com/personal-finance/24/09/41075540/is-your-401-k-balance-above-average-find-out-if-youre-beating-most-savers">pull the rest from her 401(k)</a>, cash out her Roth IRA, and absolutely not touch her crypto.
"I thought that would be an option to sell my crypto," she told Ramsey, "but it sounds like Freddie Mac and such have not made legislation that allows me to use that."
Ramsey wasn't buying it—literally or figuratively. "No," he said flatly. "If you sell your crypto and you have the cash, sell the crypto."
When she revealed she had about $30,000 worth of it, but wanted to keep it, Ramsey fired back: "You're broke. Sell it."
Trending: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
To be clear, Stephanie makes around $130,000 a year and had already put down earnest money. But her remaining cash was tied up in retirement accounts and crypto—none of which Ramsey considered liquid or smart to mess with for a house. Especially not one this expensive.
"You're going to get hit with a 10% penalty plus your tax rate," Ramsey warned. "You're going to get hit with 40%." Then, delivering one of the most memorable lines of the segment, he said, "Dave, I want to borrow money at 40% interest to buy this house… I would say no, don't do that. That doesn't sound wise. And that is exactly what you're doing."
Ramsey wasn't finished. He told her she needed at least $20,000 in the bank after closing or she'd be one bad roof away from financial disaster. "As soon as you move in, crap's gonna fall in," he said. "You're asking for trouble being broke and buying a house."
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
In the end, his advice was clear: sell the crypto, <a href="https://www.benzinga.com/personal-finance/25/05/45181755/58-year-old-with-no-retirement-says-his-ex-left-him-broke-and-hes-sick-of-working-dave-ramsey-says-he-can-build-a-500k-nest-egg-in-10-years">don't touch retirement accounts</a>, and make sure there's a cash cushion to fall back on. "It's not a blessing to buy a house when you're broke," he said. "You just got the 28-year-old fever. I gotta have a house. Especially a three-quarter-of-a-million-dollar house."
As for the crypto loyalty? Ramsey didn't hold back: "It's cool to sit at some hipster bar and be like, ‘I got crypto.' You're broke. Sell it."
It wasn't the pep talk Stephanie may have hoped for—but it was pure, unfiltered Dave Ramsey. And for anyone rushing headfirst into homeownership with big dreams and zero reserves, the message was simple: the bank may approve you, but that doesn't <a href="https://www.benzinga.com/money/are-you-rich">mean you can actually afford it</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

28-Year-Old Refuses to Sell Crypto, But Wants to Drain Her 401(k) And IRA For A $750K House — Dave Ramsey Tells Her 'You're Too Broke'

Leading sports brand ESPN is launching a new direct-to-consumer streaming platform under the flagship ESPN brand. Here's a look at what this means for Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) and<a href="https://www.benzinga.com/topic/streaming"> the streaming sector.</a>
What Happened: ESPN announced this week that<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40946689/disney-faces-more-change-ahead-as-espn-dtc-launch-will-accelerate-cord-cutting-nba-"> its long-awaited DTC</a> streaming platform will debut in the fall with a $29.99 per month price point.
"We are providing everything ESPN has to offer directly to fans and all in one place," ESPN Chairman Jimmy Pitaro <a href="https://www.espn.com/espn/story/_/id/45126967/espn-direct-consumer-streaming-service-set-fall-launch">said</a>.
Pitaro said ESPN is the most "trusted, loved and recognized name in sports."
"Our straightforward approach to name and pricing will help fans cut through the clutter, and provide them compelling options to access all our content within the enhanced ESPN App."
Pitaro said the app will be "the ultimate sports destination."
ESPN announced that users can buy an annual subscription for $299 per year, saving on the monthly cost.
ESPN+, the company's already existing streaming platform, will continue to be offered for $11.99 per month or $119 per year. There is also bundling options with other Disney streaming platforms, including Disney+ and Hulu.
Consumers who subscribe to the new streaming app will get access to seven ESPN domestic linear networks, along with ESPN on ABC and other streaming options. The company said consumers will get access to over 47,000 live events a year, along with on-demand replays, studio shows and original programming.
Additional details about the service, including a launch date, will be announced this summer.
Read Also:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45293256/disney-stock-resilient-in-uncertain-economy-as-raised-guidance-signals-confidence"> Disney Stock &#8216;Resilient&#8217; In Uncertain Economy As Raised Guidance Signals Confidence</a>
Why It's Important: The new streaming platform could be one of the final nails in the coffin for cable television, with live sports being one of the top reasons consumers have cable over streaming platforms.
Users will now be able to secure the ESPN and ESPN family of channels on their own outside of cable, a move that LightShed Partners analyst Rich Greenfield <a href="https://lightshedtmt.com/2025/05/14/espns-direct-to-consumer-trojan-horse/">said </a>could help Disney.
Greenfield predicted earlier this year that Disney would have two million ESPN DTC subscribers by the end of 2025.
"We feel even more confident after ESPN revealed their pricing and packaging yesterday," Greenfield said.
The analyst said the goal of launching the ESPN app direct-to-consumer could be to get existing ESPN subscribers to watch via the app instead of with a multichannel video programming distributor, or MVPD.
"If ESPN can drive MVPD and vMVPD subscribers to use the ESPN app instead of watching on Comcast, DirecTV, or YouTube TV, they will finally have a direct relationship with their viewers."
Greenfield said this would give Disney more options when it comes to targeting advertising and engaging with fans in other ways, such as through fantasy sports, merchandise and sports betting.
"We believe the best way to judge ESPN's DTC effort is not by DTC subscribers at year-end 2025 or 2026, but rather how many consumers are using the ESPN app in a year to watch ESPN and how much time spent occurs on the ESPN app."
The analyst said getting a "meaningful portion" to watch through the app would be a "big win for Disney."
"If not, the ESPN DTC launch will be a relatively minor event that helps offset the continued decline in multichannel video universe subscribers."
Greenfield highlighted in the recent note that Disney CEO Bob Iger previously called the launch of the ESPN DTC app the biggest development for the sports company since landing Monday Night Football rights in 2005.
DIS Price Action: Disney stock was up 1.35% to $112.94 at market close on Wednesday versus a 52-week trading range of $80.10 to $118.63. Disney stock is up 1.9% year-to-date in 2025 and up 7.25% over the past year.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/education/25/05/45262536/disney-expands-to-abu-dhabi-with-new-theme-park-heres-how-the-stock-performs-after-park-openings">Disney Expands To Abu Dhabi With New Theme Park: Here&#8217;s How The Stock Performs After Park Openings</a></li>
</ul>

Analyst Color

Entertainment

Sports

Analyst Ratings

Media

ESPN To Launch 'Ultimate Sports Destination' Streaming App In Fall: Why Analyst Says Disney Can 'Have A Direct Relationship With Their Viewers'

Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) has outperformed the market over the past 10 years by 6.03% on an annualized basis producing an average annual return of 16.71%. Currently, Fiserv has a market capitalization of $105.26 billion. 
Buying $1000 In FI: If an investor had bought $1000 of FI stock 10 years ago, it would be worth $4,661.43 today based on a price of $189.86 for FI at the time of writing.
<h3>Fiserv's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747260918_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Battalion Oil (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BATL#AMEX">BATL</a>) reported quarterly losses of $(1.00) per share. This is a 55.36 percent increase over losses of $(2.24) per share from the same period last year. The company reported $47.48 million in sales this quarter. This is a 4.80 percent decrease over sales of $49.87 million the same period last year.

Earnings

BATL

UPDATE: Battalion Oil Q1 Adj. EPS $(1.00) Up From $(2.24) YoY, Sales $47.48M Down From $49.87M YoY

Foot Locker Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) shares are running after the market close on Wednesday following reports that Dick&#8217;s Sporting Goods Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) is nearing a deal to buy the <a href="https://www.benzinga.com/pressreleases/25/05/n45129350/foot-locker-inc-to-report-first-quarter-financial-results-on-thursday-may-29">footwear and apparel retailer</a>.
What To Know: Dick&#8217;s Sporting Goods is getting close to finalizing a deal to acquire Foot Locker for around $2.3 billion, according to a Wall Street Journal <a href="https://www.wsj.com/business/deals/dicks-sporting-goods-nears-deal-to-buy-foot-locker-7ecf9194">report</a>. 
The report indicates that a deal could be completed as soon as Thursday, citing people familiar with the matter. 
Discussions have reportedly involved a potential deal at $24 per share, representing a significant premium to Foot Locker&#8217;s closing price of $12.88 as of Wednesday&#8217;s close. 
Foot Locker shares have trended down since the start of the year. Shares sold off in February as markets began to move lower in anticipation of <a href="https://www.benzinga.com/trading-ideas/25/04/44672618/trump-tariffs-to-hurt-nike-under-armour-vf-are-ralph-lauren-foot-locker-safer-bets">tariffs</a> from the Trump administration. The company also reported mixed financial results in March as sales fell 5.8% year-over-year. Foot Locker guided for continued consumer and category promotional pressures and said it would continue to focus on inventory controls and expense management. 
The Wall Street Journal reported that the deal would be the biggest acquisition to date for Dick&#8217;s, the nation&#8217;s largest sports retail chain. The deal would also expand Dick&#8217;s operations outside the U.S. 
Dick&#8217;s Sporting Goods shares were down about 4.58% at $200, while Foot Locker shares were soaring 68.61% at $21.70 after-hours Wednesday at publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Foot Locker is due to report <a href="https://www.benzinga.com/calendars/earnings">first-quarter financial results</a> on May 29. Analysts have been anticipating a loss of four cents per share and revenue of $1.86 billion.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/insights/analyst-ratings/25/05/45357794/beyond-the-numbers-13-analysts-discuss-dicks-sporting-goods-stock">Beyond The Numbers: 13 Analysts Discuss Dick&#8217;s Sporting Goods Stock</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/Fotocute">C. Nass</a>/Shutterstock.

After-Hours Center

Foot Locker Stock Soars On Potential Dick's Sporting Goods Deal: Report

Fury Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FURY#AMEX">FURY</a>) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year.

FURY

Fury Gold Mines Q1 GAAP EPS $(0.02) Down From $(0.01) YoY

Spire Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.67) by 5.97 percent. This is a 18.87 percent decrease over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $23.90 million which beat the analyst consensus estimate of $22.70 million by 5.31 percent. This is a 6.96 percent decrease over sales of $25.69 million the same period last year.

Earnings Beats

SPIR

CORRECTION: Spire Global Q1 Adj. EPS $(0.63) Beats $(0.67) Estimate, Sales $23.90M Beat $22.70M Estimate

Across the recent three months, 14 analysts have shared their insights on OneStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OS#NASDAQ">OS</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">11</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for OneStream, revealing an average target of $29.5, a high estimate of $35.00, and a low estimate of $24.00. This current average has decreased by 11.81% from the previous average price target of $33.45. 
<img src="https://www.benzinga.com/files/images/story/2025/1747260078_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of OneStream by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Koji Ikeda</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$33.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Brett Huff</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$30.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Brian Peterson</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$29.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$32.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Outperform</td>
<td>$30.00</td>
<td>-</td>
</tr>
<tr>
<td>Nick Altmann</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$27.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$24.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Chris Quintero</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$27.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Terry Tillman</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$27.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Adam Hotchkiss</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$31.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Brett Huff</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$27.00</td>
<td>-</td>
</tr>
<tr>
<td>Brett Huff</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$27.00</td>
<td>-</td>
</tr>
<tr>
<td>Chris Quintero</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$34.00</td>
<td>$37.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to OneStream. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of OneStream compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for OneStream's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into OneStream's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/OS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on OneStream analyst ratings.</a>
<h2>Delving into OneStream's Background</h2>
OneStream Inc is an AI-enabled and extensible software platform that unifies core financial functions and broader operational data and processes within a single platform. The Digital Finance Cloud of the company provides a comprehensive, dynamic, and predictive view of the entire enterprise, providing corporate leaders the control, visibility, and agility required to proactively adjust business and day-to-day execution. Company platform unifies core financial and operational data and processes within a single platform, with solutions that maintain the integrity of corporate reporting standards for Finance while providing operationally insights for business users.
<h3>Key Indicators: OneStream's Financial Health</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3M period, OneStream showcased positive performance, achieving a revenue growth rate of 23.59% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: OneStream's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -17.62%, the company may face hurdles in effective cost management.
Return on Equity (ROE): OneStream's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -6.01%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): OneStream's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -2.84%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.04, OneStream adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down OneStream: 14 Analysts Share Their Views

Ratings for Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $1.88, with a high estimate of $2.50 and a low estimate of $1.50. A decline of 37.33% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1747260071_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Biodesix by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bill Bonello</td>
<td>Craig-Hallum</td>
<td>Lowers</td>
<td>Buy</td>
<td>$1.50</td>
<td>$3.00</td>
</tr>
<tr>
<td>Thomas Flaten</td>
<td>Lake Street</td>
<td>Lowers</td>
<td>Buy</td>
<td>$2.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Kyle Mikson</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$1.50</td>
<td>$2.50</td>
</tr>
<tr>
<td>Kyle Mikson</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$2.50</td>
<td>$3.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Biodesix. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Biodesix compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Biodesix's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Biodesix's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BDSX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Biodesix analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Discovering Biodesix: A Closer Look</h2>
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
<h3>A Deep Dive into Biodesix's Financials</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Biodesix showcased positive performance, achieving a revenue growth rate of 39.28% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Biodesix's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -40.39%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -33.86%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Biodesix's ROA excels beyond industry benchmarks, reaching -8.25%. This signifies efficient management of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.97, caution is advised due to increased financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BDSX

Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Ralph Lauren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $279.57, along with a high estimate of $342.00 and a low estimate of $219.00. Highlighting a 0.76% decrease, the current average has fallen from the previous average price target of $281.71. 
<img src="https://www.benzinga.com/files/images/story/2025/1747260062_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Ralph Lauren among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$275.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$335.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$260.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$240.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$219.00</td>
<td>$282.00</td>
</tr>
<tr>
<td>Brooke Roach</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$286.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$342.00</td>
<td>$285.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Ralph Lauren. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ralph Lauren compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Ralph Lauren's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Ralph Lauren's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/RL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Ralph Lauren analyst ratings.</a>
<h2>Get to Know Ralph Lauren Better</h2>
Founded by designer Ralph Lauren in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.
<h3>A Deep Dive into Ralph Lauren's Financials</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Ralph Lauren's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 10.83%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Ralph Lauren's net margin excels beyond industry benchmarks, reaching 13.87%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Ralph Lauren's ROE excels beyond industry benchmarks, reaching 11.94%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 4.29%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.06.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Ralph Lauren: 7 Analysts Share Their Views

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $143.68, along with a high estimate of $171.44 and a low estimate of $132.00. Experiencing a 2.01% decline, the current average is now lower than the previous average price target of $146.63. 
<img src="https://www.benzinga.com/files/images/story/2025/1747260047_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive BioNTech. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Robert Burns</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Buy</td>
<td>$134.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Geoff Meacham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$140.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Terence Flynn</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$132.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Robert Burns</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Buy</td>
<td>$145.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Geoff Meacham</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Buy</td>
<td>$145.00</td>
<td>-</td>
</tr>
<tr>
<td>Terence Flynn</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$139.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>John Newman</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$171.44</td>
<td>$171.44</td>
</tr>
<tr>
<td>Etzer Darout</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$143.00</td>
<td>$130.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to BioNTech. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of BioNTech compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for BioNTech's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into BioNTech's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BNTX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on BioNTech analyst ratings.</a>
<h2>All You Need to Know About BioNTech</h2>
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
<h3>Key Indicators: BioNTech's Financial Health</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: BioNTech's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -2.56%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: BioNTech's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -227.46%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): BioNTech's ROE stands out, surpassing industry averages. With an impressive ROE of -2.17%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): BioNTech's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -1.9%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.02.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BNTX

Where BioNTech Stands With Analysts

KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) has been analyzed by 14 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">8</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for KKR, presenting an average target of $135.93, a high estimate of $194.00, and a low estimate of $114.00. Observing a downward trend, the current average is 11.45% lower than the prior average price target of $153.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1747260037_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of KKR by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$120.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$141.00</td>
<td>$129.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$136.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$131.00</td>
<td>$129.00</td>
</tr>
<tr>
<td>Vikram Gandhi</td>
<td>HSBC</td>
<td>Lowers</td>
<td>Buy</td>
<td>$119.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$114.00</td>
<td>$156.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$129.00</td>
<td>$181.00</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$126.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$120.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Chris Allen</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$132.00</td>
<td>$177.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$150.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$194.00</td>
<td>$214.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$141.00</td>
<td>$150.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to KKR. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of KKR compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for KKR's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into KKR's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/KKR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on KKR analyst ratings.</a>
<h2>Unveiling the Story Behind KKR</h2>
KKR is one of the world's largest alternative asset managers, with $624.4 billion in total managed assets, including $505.7 billion in fee-earning AUM, at the end of September 2024. The company has two core segments: asset management (which includes private markets-private equity, credit, infrastructure, energy, and real estate-and public markets-primarily credit and hedge/investment fund platforms) and insurance (following the firm's initial investment in, and then ultimate purchase of, Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance).
<h3>Unraveling the Financial Story of KKR</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Negative Revenue Trend: Examining KKR's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -68.18% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: KKR's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -6.53%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -0.82%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): KKR's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.05%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.04, caution is advised due to increased financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying KKR: Insights From 14 Analyst Reviews

Ratings for Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Corteva and provided 12-month price targets. The average target is $73.2, accompanied by a high estimate of $79.00 and a low estimate of $69.00. This current average has increased by 4.08% from the previous average price target of $70.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1747260029_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Corteva. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Richard Garchitorena</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$79.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$71.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$78.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$72.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$76.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Bradley Thomas</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$71.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Bill Selesky</td>
<td>Argus Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$69.00</td>
<td>$69.00</td>
</tr>
<tr>
<td>Duffy Fischer</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$71.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Corteva. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Corteva compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Corteva's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Corteva's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CTVA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Corteva analyst ratings.</a>
<h2>Discovering Corteva: A Closer Look</h2>
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
<h3>A Deep Dive into Corteva's Financials</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Challenges: Corteva's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -1.67%. This indicates a decrease in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Corteva's net margin is impressive, surpassing industry averages. With a net margin of 14.76%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.71%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Corteva's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.57% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Corteva's debt-to-equity ratio is below the industry average at 0.17, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTVA

Expert Outlook: Corteva Through The Eyes Of 10 Analysts

In the current market session, Kennametal Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>) share price is at $21.68, after a 2.17% drop. Over the past month, the stock increased by 15.20%, but over the past year, it actually decreased by 16.65%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1747260022_0.png" alt="Past Year Chart" />

<h3>Comparing Kennametal P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Kennametal has a lower P/E than the aggregate P/E of 34.55 of the Machinery industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1747260022_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Kennametal

Wix.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) has outperformed the market over the past 10 years by 11.95% on an annualized basis producing an average annual return of 22.63%. Currently, Wix.com has a market capitalization of $10.56 billion. 
Buying $1000 In WIX: If an investor had bought $1000 of WIX stock 10 years ago, it would be worth $7,950.10 today based on a price of $189.61 for WIX at the time of writing.
<h3>Wix.com's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747260015_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Wix.com Stock In The Last 10 Years

North American (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOA#NYSE">NOA</a>) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.52 by 30.77 percent. This is a 37.93 percent decrease over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $237.43 million which beat the analyst consensus estimate of $212.74 million by 11.61 percent. This is a 7.74 percent increase over sales of $220.37 million the same period last year.

Earnings Misses

CORRECTION: North American Q1 Adj. EPS $0.36 Misses $0.52 Estimate, Sales $237.43M Beat $212.74M Estimate

<a href="https://www.youtube.com/watch?v=NmJrdyWxgfo">https://www.youtube.com/watch?v=NmJrdyWxgfo</a>

Macro Economic Events

Economics

Federal Reserve

General

Fed's Daly Says Monetary Policy Well-Positioned, Moderately Restrictive; Says Businesses Are Cautious Amid Uncertainty, But Not Stalling Out; Says Solid Growth, Solid Labor Market, Declining Inflation; Says That's Where We Want To Be; Says Fed Policy Can Respond To Whatever Comes In The Economy; Says Patience Is The Word Of The Day

<a href="https://www.reuters.com/business/world-at-work/amazon-trims-jobs-devices-services-unit-2025-05-14/">https://www.reuters.com/business/world-at-work/amazon-trims-jobs-devices-services-unit-2025-05-14/</a>

AMZN

'Amazon trims jobs in devices and services unit'- Reuters

PermRock Royalty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRT#NYSE">PRT</a>) reported quarterly earnings of $0.12 per share. This is a 30.43 percent increase over earnings of $0.09 per share from the same period last year. The company reported $1.72 million in sales this quarter. This is a 31.43 percent increase over sales of $1.31 million the same period last year.

PermRock Royalty Trust Q1 EPS $0.12 Up From $0.09 YoY, Sales $1.72M Up From $1.31M YoY

Tuesday was a bullish eye-opener for investors in <a target="_blank" href="https://www.benzinga.com/topic/technology-stocks" rel="noreferrer noopener">U.S. tech stocks</a>, as it&#8217;s becoming crystal clear that the AI Revolution has found its next major area of penetration: Saudi Arabia, Wedbush analyst Daniel Ives said.
Joining President Trump and his team of advisors on this key trip to the Middle East starting at the Saudi-U.S. Investment Forum he was joined by titans of the tech world including Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) Godfather of AI Jensen, Elon Musk, Amazon.Com Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Andy Jassy, Palantir Technologies Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) Alex Karp, Alphabet Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Ruth Porat, International Business Machines Corp&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) Arvind Krishna, OpenAI&#8217;s Sam Altman, Advanced Micro Devices, Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) Lisa Su, among other prominent tech leaders.
The theme was clear in Riyadh: the AI Revolution is coming to the Saudi Kingdom, and Riyadh will be a major buyer of AI chips, software, autonomous robotics, and data centers over the next decade.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/buybacks/25/05/45410939/amd-stock-pops-on-6-billion-buyback-plan-us-tariff-ease" rel="noreferrer noopener">AMD Stock Pops On $6 Billion Buyback Plan, U.S. Tariff Ease</a>
Coming off a major US and China trade deal this weekend in Switzerland, which was a &#8220;dream scenario&#8221; for the markets and bullish tech investors, the tone in Riyadh has been about the bright green light on the massive AI buildout in Saudi, and this could open up a vast opportunity and TAM for Nvidia, Palantir, Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Amazon, Alphabet, Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and many other well-positioned chip/software names over the coming years.
Ives noted that the market opportunity in Saudi Arabia could add another $1 trillion to the broader global AI market in the coming years, and this dynamic is not being priced into the market and tech names.
Trump granted the Crown Prince&#8217;s new AI company, Humain (PIF AI subsidiary), a major strategic partnership with Nvidia in which Jensen &amp; Co. will sell 18,000 next-generation Blackwell chips in the first deployment to power a Saudi supercomputer.
Over the next five years, Saudi Arabia will construct major data centers to train and deploy the Kingdom&#8217;s sovereign AI models.
This technology innovation is part of Saudi Arabia&#8217;s Vision 2030 initiative to move away from dependence and focus on technology and other strategic initiatives.
This is all part of a regional focus in the Middle East on building out data centers and the AI Revolution, which will start to vault UAE, Saudi, and Qatar to the priority list for U.S. tech companies. It also speaks to this global game of high-stakes poker being played by the Trump Administration, as while China is getting restrictions from Nvidia&#8217;s older H20 chip slowing down the AI buildout in Beijing, on the contrary, Ives noted Saudi getting the best Nvidia next-generation chips with a red carpet rollout from the rest of the Big Tech world.
China is taking notice, which will add to the drama of the broader U.S.-China tariff talks over the coming months.
This Saudi development is a significant trend to focus on over the coming months. As per the analyst, the AI theme is a bullish indicator that further shows the U.S. tech&#8217;s lead in this fourth Industrial Revolution.
He stated that there is one chip fueling this generational spending: the Godfather of AI, Jensen and Nvidia. This will be just the beginning as tech players like the hyperscalers, Palantir, Tesla, and others see the game-changing AI market opportunity in the Middle East. Ives expects bigger AI deals on the horizon, Ives added.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45411148/taiwan-semiconductor-commits-15-billion-to-chip-expansion-approves-dividend-amid-rising-global-demand" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor Commits $15 Billion To Chip Expansion, Approves Dividend</a></li>
</ul>
Photo by AKOBCHUK V via Shuttesrtock

Tech

GOOG

GOOGL

MSFT

NVDA

PLTR

TSLA

Nvidia, Amazon, Tesla, Palantir Among Top Beneficiaries Of $1 Trillion Saudi Arabia AI Push, Analyst Says

Press Releases

Trip.com Group Highlights Golden Week 2024 Travel Shifts: Chinese Tourists Explore Beyond Capitals and Lesser-Known Options

Trip.com Group Limited to Report Third Quarter of 2024 Financial Results on November 18, 2024 U.S. Time

Trip.com Group Limited Reports Unaudited Third Quarter of 2024 Financial Results

Trip.com Group Announces Changes in Board Composition

Trip.com Group Limited to Report Fourth Quarter and Full Year of 2024 Financial Results on February 24, 2025 U.S. Time

Trip.com Group Limited Reports Unaudited Fourth Quarter and Full Year of 2024 Financial Results

Offerings

Baidu Announces Proposed Offering of Exchangeable Bonds

Baidu Announces Pricing of US$2 Billion Offering of Zero Coupon Exchangeable Bonds

Trip.com Group Filed 2024 Annual Report on Form 20-F

Trip.com Group Limited to Report First Quarter of 2025 Financial Results on May 19, 2025 U.S. Time

BIDU

Airbnb

Atour Lifestyle Holdings Limited - American Depositary Shares

Atour Lifestyle Holdings

Booking Holdings

Choice Hotels International, Inc. Common Stock

Choice Hotels Intl

Despegar.com

Expedia Group

Global Business Travel Group, Inc. Class A Common Stock

Global Business Travel

GreenTree Hospitality Group Ltd. American depositary shares, each representing one Class A ordinary share

GreenTree Hospitality Gr

Hyatt Hotels Corporation Class A Common Stock

Hyatt Hotels

Hilton Grand Vacations

Hilton Worldwide Holdings Inc. Common Stock

Hilton Worldwide Holdings

H World Group Limited - American Depositary Shares

H World Group

Intercontinental Hotels Group American Depositary Shares (Each representing one Ordinary Share)

InterContinental Hotels

Lindblad Expeditions Holdings Inc. - Common Stock

Lindblad Expeditions

Marriott International - Class A Common Stock

Marriott International

MakeMyTrip

Norwegian Cruise Line Holdings Ltd. Ordinary Shares

Norwegian Cruise Line

Royal Caribbean Cruises Ltd. Common Stock

Royal Caribbean Gr

Sabre

Soho House & Co Inc. Class A Common Stock

Soho House

Target Hospitality

Travel+Leisure

Marriott Vacations Worldwide Corporation Common Stock

Marriott Vacations

Viking Holdings

Wyndham Hotels & Resorts, Inc. Common Stock

Wyndham Hotels & Resorts

JP Morgan

Benchmark

Citigroup

Barclays

Macquarie

수요일(9일) 오후 도널드 트럼프 대통령이 미국의 무역 조치에 보복하지 않은 국가에 대한 <a href="https://www.benzinga.com/25/04/44720006/markets-take-off-as-trump-announces-90-day-tariff-pause-for-non-retaliating-nations-slaps-china-with-125-duty" target="_blank" rel="noopener">추가 관세 90일 유예</a>를 발표했다. 이에 대형 중국 기업 주식을 추종하는 iShares China Large-Cap ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NASDAQ">FXI</a>)가 반등해 7% 상승 마감했다. 
하지만 트럼프의 중국 수입에 대한 125% 관세 발표는 미국-중국 긴장에 대한 투자자들의 우려를 더욱 키웠고, 대형 중국 주식의 성과는 주요 미국 지수에 비해 부진했다. 
알아두어야 할 사항: FXI는 대형 중국 주식에 대한 노출을 제공하는 ETF로, 알리바바 그룹 홀딩 리미티드 ADR(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), JD닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), 트립닷컴 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>)을 포함한다. FXI는 수요일 오후 개선된 글로벌 무역 심리에 힘입어 상승했다.
그러나 중국이 여전히 트럼프 행정부의 무역 조치 확대의 <a href="https://www.benzinga.com/25/04/44720006/markets-take-off-as-trump-announces-90-day-tariff-pause-for-non-retaliating-nations-slaps-china-with-125-duty" target="_blank" rel="noopener">직접적인 표적</a>이 되고 있다는 사실로 인해 ETF의 상승세는 둔화되었다. 트럼프 대통령이 중국산 수입품에 대한 125% 관세 인상을 동시에 선언하면서 미중 긴장 지속에 대한 투자자들의 우려가 강화되었다.
또한 중국 경제의 구조적 문제도 <a href="https://www.benzinga.com/markets/asia/25/04/44715261/from-bad-to-terrible-treasury-secretary-slams-beijings-retaliatory-tariffs-as-trump-trade-agenda-wipes-trillions" target="_blank" rel="noopener">중국 증시 전망을 계속 압박</a>하고 있다. 국내 성장 둔화, 주요 기술 기업에 대한 지속적인 규제 조사, 환율 변동성 등으로 인해 글로벌 투자자들은 더욱 신중한 자세를 취하고 있다. 
관세 유예로 단기적으로 안도감을 줄 수 있지만, 중국 증시의 시장 대비 저조한 성과는 중국의 경제 궤적과 긴장된 미국과의 관계에 대한 지속적인 우려를 반영한다.
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

지난주 가장 좋은 성과를 보인 대형주 10개는 다음과 같다.
<ol>
<li>옥타 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>): 회사가 <a href="https://www.benzinga.com/analyst-ratings/upgrades/25/03/44108947/okta-stock-is-surging-tuesday-heres-why" target="_blank" rel="noreferrer noopener">예상보다 나은</a> 4분기 재무 실적을 발표하고, 여러 애널리스트가 <a href="https://www.benzinga.com/quote/BJ/analyst-ratings" target="_blank" rel="noreferrer noopener">주식 평가를 상향 조정하고 목표주가를 올린</a> 후 24.26% 상승했다.</li>
<li>아르셀로미탈 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MT#NYSE">MT</a>): 금과 은의 강세로 19.50% 상승했다.</li>
<li>ING 그룹 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ING#NYSE">ING</a>): 회사가 7,000만 유로 규모의 자사주 매입 프로그램을 발표한 후 16.98% 상승했다.</li>
<li>포스코 홀딩스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKX#NYSE">PKX</a>): 전체 시장의 강세와 트럼프 대통령이 자동차 관세를 연기할 것이라는 보도로 인해 15.55% 상승했다.</li>
<li>모더나 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>): 스테판 반셀(Stephane Bancel) CEO가 주식 매입을 공개한 후 15.02% 상승했다.</li>
<li>엘빗 시스템즈 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLT#NASDAQ">ESLT</a>): 14.80% 상승했다.</li>
<li>BJ&#8217;s 홀세일 클럽 홀딩스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>): 회사가 예상치를 상회하는 <a href="https://www.benzinga.com//node/44165337" target="_blank" rel="noreferrer noopener">4분기 재무 실적</a>을 발표한 후 14.06% 상승했다. 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/BJ/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 전망을 상향 조정했다.</a></li>
<li>로켓 컴퍼니스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>): 12.64% 상승했다.</li>
<li>트립닷컴 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>): 중국이 2025년 GDP 성장 목표를 약 5%로 설정하고 경기 부양 조치를 발표했다고 보도한 후 12.61% 상승했다.</li>
<li>스트레티지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>): 비트코인 (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) 가격이 <a href="https://www.benzinga.com//node/44138476" target="_blank" rel="noreferrer noopener">9만 달러에 가까워졌다</a>는 소식으로 12.43% 상승했다.</li>
</ol>
이미지 출처: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

많은 국가가 2025년까지 지출을 줄이려고 노력하고 있지만, 주목할 만한 국가 중 한 곳은 바로 중국이다. 중국 정부는 침체된 경제를 부양하기 위해 일련의 경기 부양책을 약속해 왔으며, 지난주 은행 부문에 550억 달러(4,000억 위안) 이상을 투입하겠다고 발표하면서 이러한 금전적 약속 중 하나가 이행되었다.
관세 여부와 관계없이 오늘 소개하는 4가지 주식은 급등할 수 있다.
이번 자금 투입은 성장이 절실한 중국의 수요를 촉진하기 위한 광범위한 경기 부양책의 일환이다. 중국의 인플레이션은 2023년 초부터 거의 제로에 가까웠고, 생산자 물가는 실제로 2년 연속 하락했다.
미국의 소비자들은 2021년, 2022년, 2023년에 평균 4%가 넘는 CPI를 기록한 후 연간 0.2%의 인플레이션 수치를 환영할 수 있지만, 중국 경제는 어려움을 겪고 있으며 상하이종합지수(SSE)는 2022년 초부터 계속 정체되고 있다.
하지만 정부가 경기 부양책을 내놓으면서 투자자들이 다시 활기를 띠기 시작했고, 몇몇 대형 중국 기업이 직접적인 수혜자가 될 수 있다.
오늘은 중국 정부의 경기 부양책의 수혜를 받을 수 있는 미국 상장 중국 기업 4곳을 살펴보고자 한다. 이 기업들은 대부분 대형주이지만 다양한 산업과 부문에 걸쳐 있다. 또한 이들 주식 중 일부는 2월 말 트럼프 행정부의 새로운 관세 위협 이후 주가가 하락했는데, 3월이 시작되면서 현명한 투자자에게는 매수 기회가 될 수 있다.
<h3 class="wp-block-heading">알리바바 그룹 홀딩스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)</h3>
알리바바는 마침내 제대로 된 이유로 헤드라인을 장식하고 있다. 최근 실적 보고서는 애널리스트들로부터 수많은 투자의견 상향을 이끌어냈다. 중국 이커머스 대기업 알리바바는 2월 20일 보고서에서 매출 및 순이익 모두에서 예상치를 초과 발표하여 주가 상승을 이끌었고, 연초 대비(YTD) 50% 이상의 상승률을 기록했다. 특히 핵심 마켓플레이스 매출(CMR)과 AI가 접목된 알리클라우드(AliCloud) 부문과 같은 주요 영역에서 견고한 성장세를 보였다.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" class="wp-image-806846" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154849/ali-1024x415.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154849/ali-1024x415.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154849/ali-300x121.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154849/ali-768x311.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154849/ali.png 1309w" alt="" width="1024" height="415" /></figure>
이러한 수치와 12월 중국 소매판매가 전년 대비 3.7% 증가했다는 점을 감안하면 알리바바 주가는 추가 상승의 발판을 마련한 것으로 보인다. 금요일에는 새로운 관세 위협으로 인해 주가가 하락했지만, 애널리스트들이 등급과 목표주가를 상향 조정하면서 강세 기조가 강화되었다.
2월 20일 실적 보고서가 나온 후 번스타인과 모건스탠리는 즉시 보유에서 매수 의견으로 상향 조정했고, JP모건, BofA 증권, 바클레이즈, 벤치마크의 애널리스트들 역시 모두 목표주가를 올렸다. 새로운 목표주가 중 가장 낮은 가격(150달러)은 2월 28일 종가 대비 12.6%의 상승 여력이 있음을 의미한다.
<h3 class="wp-block-heading">트립닷컴 그룹 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>)</h3>
중국의 엄격한 코로나19 제한 조치로 여행 수요가 위축되었지만, 트립닷컴은 코로나19에 대해 알기 훨씬 전부터 어려움을 겪고 있었다. 2017년 7월 주가는 사상 최고치를 기록한 후 이후 5년 동안 꾸준히 하락했다. 2022년 10월에는 2014년 수준으로 급락했고, 2022회계연도에는 상당한 손실을 기록할 것으로 예상되었다.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" class="wp-image-806847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154856/tri-1024x415.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154856/tri-1024x415.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154856/tri-300x121.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154856/tri-768x311.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154856/tri.png 1309w" alt="" width="1024" height="415" /></figure>
그러나 트립닷컴 주가는 2022년 마지막 몇 달 동안 턴어라운드하기 시작했다. 2023년의 고르지 못한 주가 흐름 이후, 2024년에 주가가 급등하여 7년 만에 사상 최고치를 기록했다. 트립닷컴 주가는 2025년을 시작하며 하락세로 돌아섰고, 불과 몇 주 만에 77달러에서 56달러로 떨어졌다.
하지만 이러한 하락은 투자자들에게는 기회가 될 수 있다. 트립닷컴은 부채가 적고 수익의 16배에 불과한 주가로 거래되고 있다. 최근 2024년 4분기 실적에서 매출과 순이익 모두 예상치를 초과했다. 벤치마크와 JP모건은 각각 80달러와 75달러의 목표주가를 제시하고 매수 의견을 반복했다. 75달러는 현재 수준에서 거의 28% 상승 여력이 있는 가격이다.
기술적 관점에서 볼 때 상대강도지수(RSI)가 주요 임계치인 30까지 계속 하락함에 따라 곧 과매도 신호를 유발할 수 있다.
<h3 class="wp-block-heading">핀볼루션 그룹 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FINV#NYSE">FINV</a>)</h3>
핀볼루션 그룹은 시가총액이 21억 4,000만 달러에 불과해 이 목록에서 가장 작은 주식이다. 하지만 다른 종목들과 마찬가지로 오랜 고군분투 끝에 2024년에 부활의 조짐을 보였다. 핀볼루션은 온라인 마켓플레이스를 통해 소비자와 대출자를 연결하는 데 중점을 둔 핀테크 기업이다.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" class="wp-image-806848" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154903/inv-1024x415.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154903/inv-1024x415.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154903/inv-300x121.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154903/inv-768x311.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154903/inv.png 1309w" alt="" width="1024" height="415" /></figure>
핀볼루션 주가는 2021년 밈 주식 열풍이 불었을 때 단 3개월 만에 2달러 미만에서 8달러 이상으로 급등하며 큰 화제를 모았다. 하지만 대부분의 밈 주식과 마찬가지로 FINV도 2022년 3월에는 열풍 이전 수준으로 돌아갔다. 오늘날 주가는 소매업의 광풍이 아닌 진정한 성장 덕분에 주당 8달러에 가까운 가격으로 다시 거래되고 있다.
핀볼루션은 지난 12개월 동안 주당순이익이 12% 이상 성장했지만, 여전히 순방향 주가수익비율 5.65, 주가순자산비율 0.58로 수익의 7배에 불과한 수준에서 거래되고 있다. 핀볼루션은 2025년에 EPS가 13% 이상 성장할 것으로 예상하고 있으며, 주가는 이미 2025년에 21% 이상 상승했다. 시가총액이 작기 때문에 애널리스트의 커버리지는 적지만 펀더멘털과 기술적 신호 모두 앞으로 더 많은 잠재적 이익을 가리킨다.
<h3 class="wp-block-heading">JD닷컴 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>)</h3>
알리바바닷컴이 타사 구매자와 판매자를 위한 비즈니스 마켓플레이스라면 JD닷컴은 중국판 아마존에 가깝다. JD닷컴은 세계에서 가장 광범위한 이커머스 운영과 고품질 제품 및 고객 서비스로 명성을 얻고 있다. 600억 달러의 시가총액은 알리바바의 3,150억 달러에 비하면 미미한 수준이지만, JD닷컴은 인상적인 수익 성장에도 불구하고 여전히 저평가되어 있다.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" class="wp-image-806849" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154911/jD-1024x415.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154911/jD-1024x415.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154911/jD-300x121.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154911/jD-768x311.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03154911/jD.png 1309w" alt="" width="1024" height="415" /></figure>
JD닷컴 주가는 2021년 초에 정점을 찍은 후 급격한 하락을 경험했다. 2021년 1월에 100달러를 돌파한 주가는 2024년 1분기 초에 22달러 아래로 급락했다. 80% 하락은 위험 감수성이 높은 투자자도 겁을 먹기에 충분하지만, 작년에 회사가 안정화되면서 주가는 반등하기 시작했다. JD닷컴은 최근 4분기 동안 1,563억 3,000만 달러의 매출을 올렸으며, 이는 이전 4분기보다 3% 증가한 수치다.
JD닷컴은 3월 6일에 2024년 4분기 실적을 발표할 예정이며, 애널리스트들은 코로나19 사태 이후 최고치인 450억 달러의 매출을 예상하고 있다. 바클레이즈는 2월 28일 보고서를 앞두고 목표주가를 50달러에서 55달러로 상향 조정했는데, 이는 현재 시장 가격 대비 24% 높은 수준이다.
이미지 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

지난주에 가장 저조한 성과를 보인 12개의 대형주는 다음과 같다.
<ol>
<li>슈퍼마이크로컴퓨터 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>): 회사의 분기 보고서가 미국 <a href="https://www.benzinga.com//node/44046734" target="_blank" rel="noreferrer noopener">증권거래위원회</a>에 제출된 후 지속적인 변동성으로 인해 26.06% 하락했다.</li>
<li>앱러빈 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>): <a href="https://www.benzinga.com//node/43981217" target="_blank" rel="noreferrer noopener">주식에 대한 여러 개의 공매도 보고서</a>가 발표된 후 21.57% 하락했다.</li>
<li>메이플베어 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>): 4분기 매출이 예상보다 저조하게 나타나고 애널리스트들이 <a href="https://www.benzinga.com//node/43985818" target="_blank" rel="noreferrer noopener">주가 전망을 수정</a>한 후 21.53% 하락했다.</li>
<li>넷앱 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>): 회사가 예상보다 저조한 3분기 매출 결과를 발표하고 4분기 및 2025회계연도 <a href="https://www.benzinga.com//node/44024261" target="_blank" rel="noreferrer noopener">조정 EPS 가이던스를 발표한</a> 후 19.81% 급락했다.</li>
<li>퓨어 스토리지 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>): 회사가 2026회계연도 <a href="https://www.benzinga.com//node/43989517" target="_blank" rel="noreferrer noopener">매출 가이던스를 예상보다 저조하게 발표</a>한 후 19.36% 하락했다. 애널리스트들은 <a href="https://www.benzinga.com/quote/pstg/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 전망을 수정했다</a>.</li>
<li>듀오링고 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>): 엇갈린 4분기 결과를 발표한 후 19.02% 하락다. <a href="https://www.benzinga.com//node/44047945" target="_blank" rel="noreferrer noopener">애널리스트들이 주가 전망을 수정했다.</a></li>
<li>비아트리스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTRS#NASDAQ">VTRS</a>): 회사가 4분기 EPS와 매출이 예상보다 저조하게 나타나고 2026회계연도 매출 및 <a href="https://www.benzinga.com//node/44019622" target="_blank" rel="noreferrer noopener">및 EPS 가이던스도 예상보다 저조하게 발표한</a> 후 17.96% 하락했다. 뱅크오브아메리카증권 애널리스트 제이슨 게버리(Jason Gerberry)는 시장수익률 하회 의견을 유지하고 <a href="https://www.benzinga.com/quote/vtrs/analyst-ratings" target="_blank" rel="noreferrer noopener">목표주가를 11달러에 10달러로 하향 조정했다.</a></li>
<li>셈프라 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRE#NYSE">SRE</a>): 회사가 4분기 결과를 발표하고 전망을 하향 조정한 후 17.83% 하락했다. 여러 애널리스트들이 <a href="https://www.benzinga.com//node/43984834" target="_blank" rel="noreferrer noopener">목표주가를 수정했다</a>.</li>
<li>팔란티어 테크놀로지 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>): 지난주 보도에서 트럼프 행정부가 <a href="https://www.benzinga.com//node/44032909" target="_blank" rel="noreferrer noopener">국방부에 예산 삭감을 계획하라고 지시했다</a>고 제시한 후 지속적인 약세가 우려되어 16.21% 하락했다.</li>
<li>트립닷컴 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>): 4분기 재무 결과를 발표한 후 15.43% 하락했다.</li>
<li>스트레티지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>): 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com//node/44037042" target="_blank" rel="noreferrer noopener">가격 하락</a> 이후 14.77% 급락했다.</li>
<li>테슬라 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>): 회사가 1월에 유럽엽합에서 새로운 자동차 등록이 감소한 <a href="https://www.benzinga.com//node/43934934" target="_blank" rel="noreferrer noopener">보고서를 발표한</a> 후 13.27% 하락했다. 이는 매그니피센트 7 종목 중 <a href="https://www.benzinga.com//node/44043021" target="_blank" rel="noreferrer noopener">거의 유일한 급락세를 보인 주식</a>이다.</li>
</ol>
사진 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

CART

DUOL

NTAP

PSTG

SMCI

VTRS

테슬라·팔란티어·스트레티지 등 지난주 급락한 대형주 12종목 (2월 24일~28일)

화요일(25일) 아침 미국 주식 선물 가격이 하락하는 가운데 투자자들의 관심을 끌 수 있는 주식은 다음과 같다.
<ul>
<li>홈디포(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>): 오늘 개장 전 실적을 발표할 예정이다. 월가는 주당순이익 3.04달러, 매출 39억 700억 달러를 예상한다. 주식은 애프터마켓에서 1.2% 하락한 378.00달러에 거래되었다.</li>
<li>큐리그 닥터페퍼(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>): 오늘 개장 전 실적을 발표할 예정이다. 월가는 주당순이익 57센트, 매출 40억 달러를 예상하고 있다. 주식은 애프터마켓에서 0.4% 상승한 34.27달러에 거래되었다.</li>
<li>트립닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>): 월요일에 긍정적인 4분기 실적을 발표했다. 애프터마켓에서 주식은 0.4% 상승한 64.89달러에 거래되었다.</li>
</ul>
자세한 내용은 <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noopener">프리마켓 보도</a>를 확인하세요.
<ul>
<li>워크데이(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>): 분기 주당순이익 1.78달러, 매출 21억 8천만 달러가 예상된다. 주식은 애프터마켓에서 0.4% 상승한 262.89달러에 거래되었다.</li>
<li>인튜이트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>): 분기 주당순이익 2.58달러, 매출 39억 3천만 달러가 예상된다. 주식은 애프터마켓에서 0.6% 상승한 570.80달러에 거래되었다.</li>
</ul>
사진 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Pre-Market Outlook

INTU

WDAY

화요일 주목해야 할 주식: 홈디포, 큐리그 닥터페퍼, 트립닷컴, 워크데이 및 인튜이트

이들 9개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 카바나(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>)의 주가는 20.93% 급락했다. 공매도 업체인 힌덴버그 리서치의 비판적인 보고서는 <a href="https://www.benzinga.com//node/42784518" target="_blank" rel="noreferrer noopener">Carvana의 회복을 &#8220;신기루&#8221;</a>로 묘사하면서 약세 정서를 강화했다.
2. 소파이 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>)의 주식은 키프, 브루옛 &amp; 우즈(Keefe, Bruyette and Woods)가 <a href="https://www.benzinga.com/quote/SOfi/analyst-ratings" target="_blank" rel="noreferrer noopener">시장 수행에서 언더퍼폼으로 하향 조정</a>한 후 10.60% 하락했다.
3. 얌 차이나 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>)의 주식은 10.40% 하락했다.
4. 테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)의 주식은 회사가 4분기 <a href="https://www.benzinga.com//node/42766117" target="_blank" rel="noreferrer noopener">생산 및 인도 수치</a>를 발표한 후 9.62% 급락했다. 애널리스트들은 주식에 대한 <a href="https://www.benzinga.com//node/42786667" target="_blank" rel="noreferrer noopener">가격 예측</a>을 수정했다.
5. 킨세일 캐피털 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>)의 주식은 JP 모건이 주식의 목표 가격을 <a href="https://www.benzinga.com/quote/knsl/analyst-ratings" target="_blank" rel="noreferrer noopener">$415에서 $412로 하향 조정</a>한 후 9.45% 하락했다.
6. 브라운 포먼(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>)의 주식은 미국 총기 건강 책임자 머시가 알코올 소비가 암 위험을 증가시킬 수 있다는 경고를 발표한 후 8.20% 하락했다.
7. 트립닷컴 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>)의 주식은 씨티그룹이 주식의 가격 예측을 <a href="https://www.benzinga.com/quote/tcom/analyst-ratings" target="_blank" rel="noreferrer noopener">$73에서 $78로 상향 조정</a>한 후 7.47% 하락했다.
8. 포멘토 이코노미코 멕시카노 S.A.B. de C.V.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMX#NYSE">FMX</a>)의 주식은 미국 공중보건국장인 비벡 머시(Vivek Murthy)가 알코올 소비와 관련된 암 위험 증가에 대해 경고한 후 7.47% 하락했다.
9. 오로라 이노베이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>)의 주식은 9.47% 하락했다.
추가 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%A6%AC%EB%B9%84%EC%95%88-%EB%AA%A8%EB%B9%8C%EC%95%84%EC%9D%B4-%EB%B0%8F-arm%EC%9D%80-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%97%AC%EC%A4%80-10/" target="_blank" rel="noopener">리비안, 모빌아이 및 Arm은 지난주 최고 성과를 보여준 10개 대형주 중 일부 (12월 30일-1월 3일)</a></li>
</ul>
이미지 출처: Tesla
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

BF/B

CVNA

KNSL

SOFI

YUMC

테슬라, 소파이 및 주류 주식이 지난주 최악의 성과를 보인 9개 대형주 중 일부 (12월 30일-1월 3일)

CNN 머니 공포·탐욕 지수는 전반적인 시장 심리가 더 하락했음을 나타내면서 지난 금요일에 &#8216;중립&#8217; 영역으로 이동했다.
금요일(15일) 미국 증시는 다우존스 지수가 장중 300포인트 이상 하락하는 등 하락세로 마감했다. S&amp;P 500 지수는 주간 2.1%의 손실을 기록했고, 나스닥 종합 지수는 3.2% 정도 하락했다. 30개 종목으로 구성된 다우존스 지수는 한 주 동안 1.2% 하락했다.
주요 기술주들은 손실을 기록했으며, 특히 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) 주가는 금요일에 3% 이상 하락했고, 마이크로소프트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) 주가는 세션 중 약 2.8% 하락했다. 그러나 테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)는 금요일에 약 3% 상승했다.
제약주는 트럼프 대통령 당선인이 로버트 F. 케네디 주니어를 보건복지부(HHS) 장관으로 임명한 후 금요일 하락세로 마감했다. 모더나(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) 주가는 7% 이상 하락했고 암젠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) 주가도 4% 이상 하락했다. SPDR S&amp;P 바이오테크 ETF는 5% 이상 하락하며 2020년 이후 최악의 한 주를 기록했다.
경제 데이터 측면에서 10월 미국 수출 가격은 전월 대비 0.8% 상승했고, 10월 수입 가격은 전월 대비 0.3% 상승했다. 10월 미국 소매판매는 전월 대비 0.4% 증가하여 9월 수정치 0.8%보다는 하락했고, 시장 예상치 0.3%는 상회했다.
정보 기술, 통신 서비스, 헬스케어 섹터가 금요일에 가장 큰 손실을 기록하면서 S&amp;P 500의 대부분의 업종이 마이너스로 마감했다. 그러나 유틸리티와 금융 섹터는 전체 시장 추세와 다르게 상승세로 마감했다.
금요일 다우존스 지수는 약 306포인트 하락한 43,444.99포인트로 마감했다. S&amp;P 500 지수는 1.32% 하락한 5,870.62포인트, 나스닥 종합지수는 2.24% 하락한 18,680.12포인트로 마감했다.
투자자들은 오늘 트립닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>), 브래디 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRC#NYSE">BRC</a>), 에이컴(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>)의 실적 발표를 기다리고 있다.
<h3>CNN 비즈니스 공포·탐욕 지수란? </h3>
CNN 공포·탐욕 지수는 현재 50.9를 기록하고 있다. 금요일에 &#8216;탐욕&#8217;에서 &#8216;중립&#8217; 영역으로 이동했으며, 이전 수치는 58.2였다.
공포·탐욕 지수는 현재 시장 심리를 측정하는 지표다. 공포가 높을수록 주가에 압력을 가하고, 탐욕이 높을수록 주가를 상승시킨다는 전제를 바탕으로 한다. 이 지수는 동일한 가중치를 가진 7가지 지표를 기준으로 계산된다. 지수의 범위는 0에서 100까지이며 0은 최대 공포를, 100은 최대 탐욕을 나타낸다.
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/stocks/%EC%9B%94%EC%9A%94%EC%9D%BC-%EC%A3%BC%EB%AA%A9%ED%95%B4%EC%95%BC-%ED%95%A0-%EC%A3%BC%EC%8B%9D-%EB%B8%8C%EB%9E%98%EB%94%94-%EC%97%90%EC%9D%B4%EC%BB%B4-it-%ED%85%8C%ED%81%AC-%ED%8C%A8%ED%82%A4/" target="_blank" rel="noopener">월요일 주목해야 할 주식: 브래디, 에이컴, IT 테크 패키징, 빗디어 및 트립닷컴</a>
사진 제공: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

AMGN

美 경제지표 발표, 엔비디아와 MS 주가 하락 후 다우 지수 300p 이상 하락: 공포·탐욕 지수는 '중립'

월요일(18알) 아침에 미국 주식 선물이 혼조세를 보이고 있는 가운데, 오늘 투자자들의 관심을 끌 수 있는 주식들은 다음과 같다.
1. 브래디 코퍼레이션 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRC#NYSE">BRC</a>)
<a href="//pro.benzinga.com/dashboard"" target="_blank" rel="noopener">벤징가 프로</a> 데이터에 따르면 월가에서는 오늘 개장 전 실적을 발표하는 브래디 코퍼레이션의 매출은 3억 6,588만 달러, 주당순이익은 1.10달러로 예상한다. 주가는 시간외 거래서 0.2% 상승한 74.38달러에 거래되었다.
2. 에이컴 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>)
애널리스트들은 장 마감 후 실적을 발표할 에이컴이 41억 4,400만 달러의 매출에 주당순이익 1.24달러를 기록할 것으로 예상한다. 주가는 시간외 거래에서 0.1% 상승한 106.99달러를 기록했다.
3. IT 테크 패키징 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITP#NYSE">ITP</a>)
IT 테크 패키징은 분기 주당순손실 20센트를 발표했고 작년과 동일한 수치였다. 매출은 전년 대비 약 59% 증가하여 2,508만 달러에 달했다. 주식은 시간외 거래에서 0.6% 하락한 0.2495달러에 거래되었다.
자세한 내용은 <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noopener">프리마켓 커버리지</a>를 확인하세요.
4. 빗디어 테크놀로지스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>)
오늘 개장 전 실적을 발표하는 빗디어 테크놀로지스는 주당순손실 10센트와 매출 7,885달러를 발표할 것으로 예상된다. 주가는 시간외 거래에서 1.1% 상승한 11.21달러에서 거래되었다.
5. 트립닷컴 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>)
장 마감 후 실적을 발표할 트립닷컴의 주당순이익은 91센트, 매출은 22억 달러로 예상된다. 주가는 시간외 거래서 0.01% 하락한 59.48달러에서 거래되었다.
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/stocks/%EC%A3%BC%EA%B0%84-%EC%A3%BC%EC%9A%94-%EC%9D%B8%EA%B3%B5%EC%A7%80%EB%8A%A5-%EB%89%B4%EC%8A%A4-%EC%97%94%EB%B9%84%EB%94%94%EC%95%84%EC%95%A0%ED%94%8C-%EA%B3%B5%EA%B8%89%EC%97%85%EC%B2%B4/" target="_blank" rel="noopener">주간 주요 인공지능 뉴스: 엔비디아·애플 공급업체들이 정책 변화에 대비, 일본의 AI 도약 등</a>
사진 제공: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

BTDR

월요일 주목해야 할 주식: 브래디, 에이컴, IT 테크 패키징, 빗디어 및 트립닷컴

지난주, 중국 중앙은행이 은행의 지급준비율(RRR)을 50bp(베이시스 포인트) 또는 0.5%포인트 인하하기로 발표하면서 미국에 상장된 중국 기업들의 <a href="https://www.benzinga.com//node/41065178" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주가가 전반적으로</a> 상승했다.
지난주 가장 좋은 성과를 보인 10개의 대형 주식이 있다. 여러분의 포트폴리오에 포함되어 있나요?
1. JD닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>)의 주식은 중국 인민은행이 은행들이 보유해야 하는 현금의 양을 줄이기로 발표하고 <a href="https://www.benzinga.com//node/41062614" target="_blank" rel="noreferrer noopener">부동산 시장 지원 계획</a>을 발표한 후 39.75% 급등했다.
2. KE 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>)의 주식은 중국이 부양책의 일환으로 최대 2,840억 달러의 국채를 발행할 것이라는 보도가 나온 후 39.18% 상승했다.
3. PDD 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>)의 주식은 중국이 부양책의 일환으로 최대 2,840억 달러의 <a href="https://www.benzinga.com//node/41026720" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">국채를 발행할 것</a>이라는 보도가 나온 후 35.52% 상승했다.
4. 리버티 브로드밴드 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBRDA#NASDAQ">LBRDA</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/41015233" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">차터 커뮤니케이션즈</a>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>)의 특별위원회에 반대 제안을 전달했다고 발표한 후 31.74% 상승했다.
5. 염 차이나 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>)의 주식은 중국의 부책 발표로 인해 27.64% 상승했다.
6. H 월드 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTHT#NASDAQ">HTHT</a>)의 주식은 중국 주식의 핀 액션으로 인해 26.43% 상승했다.
7. 트립닷컴 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>)의 주식은 중국 주식의 핀 액션으로 인해 지난 주 26.02% 상승했다.
8. 니오(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>)의 주식은 정부의 부양책 발표로 인해 중국 주식의 랠리에 동참하면서 23.48% 상승했다.
9. 윈 리조트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>)의 주식은 모건 스탠리가 중립에서 비중 확대 등급으로 상향 조정하고 목표 주가를 97달러에서 104달러로 <a href="https://www.benzinga.com/quote/WYNN/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">상향 조정</a>한 후 22.47% 상승했다.
10. 바이두(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>)의 주식은 정부의 부양책 발표로 인해 중국 주식의 랠리에 동참하면서 21.95% 상승했다.
알리바바 그룹 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)와 리 오토(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>)도 지난주 중국 주식의 랠리에 동참하여 각각 20% 이상 상승했다.
추가 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%A6%AC%EC%A0%9C%EB%84%A4%EB%A1%A0%EA%B3%BC-%EC%8A%88%ED%8D%BC-%EB%A7%88%EC%9D%B4%ED%81%AC%EB%A1%9C%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EC%95%85%EC%9D%98-%EC%84%B1%EA%B3%BC%EB%A5%BC/" target="_blank" rel="noopener">리제네론 파마, 슈퍼 마이크로 컴퓨터 및 글로벌 페이먼츠는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (9월 23일-9월 27일)</a></li>
</ul>
Photo by Eric Prouzet on Unsplash
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Emerging Markets

BEKE

CHTR

HTHT

LBRDA

WYNN

중국 주식 우세 - JD닷컴과 PDD는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (9월 23일-9월 27일)

중국의 최신 경제 부양책이 글로벌 시장에 큰 파장을 일으키고 있다. <a href="https://www.benzinga.com/topic/china" target="_blank" rel="noopener" data-google-interstitial="false">다음과 같은</a> 중국 인민은행(PBoC)의 대담한 일련의 조치에 따라 이루어졌다:
<ul>
<li>은행들의 지급준비율(RRR)을 대폭 인하</li>
<li>주요 환매조건부채권(레포, repo) 금리 인하</li>
</ul>
이에 따라 유동성 유입이 국가 금융시스템에 영향을 줄 것으로 예상된다. 목표? 경제에 약 1,400억 달러를 투입하고 성장을 촉진하기 위해 더 많은 대출을 장려한다.
이 뉴스 이후 약간의 변동성이 있었지만, 일부 미국에 상장된 중국 주식들은 여전히 애널리스트들이 선호하는 종목으로 남아 있다. 다음은 강한 상승 잠재력을 가진 3개의 대형주에 대한 분석입니다. 현재 모두 애널리스트들로부터 매수 등급을 받고 있다.
<h2 class="wp-block-heading">트립닷컴: 중국 여행 붐으로 42% 상승 준비 완료</h2>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" class="wp-image-566103" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/25131636/Screenshot-2024-09-25-at-10.36.06-PM.png" sizes="(max-width: 681px) 100vw, 681px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/25131636/Screenshot-2024-09-25-at-10.36.06-PM.png 681w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/25131636/Screenshot-2024-09-25-at-10.36.06-PM-300x181.png 300w" alt="" width="681" height="412" /></figure>
출처: <a href="https://www.benzinga.com/report/TCOM">Benzinga 주식 보고서 &#8211; TCOM</a>
이 목록의 첫 번째는 중국 최대 온라인 여행사인 트립닷컴 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>)이다. 지난 1년 동안 주가는 43% 이상 급등했으며, 연초부터 현재까지 무려 44%의 놀라운 상승률을 기록했다.
분석가들은 중국의 여행 부문이 반등하고 있는 가운데 중국 내 여권 보급률이 여전히 낮은 상황에서 트립닷컴의 잠재력에 대해 특히 낙관하고 있다. 해외 여행이 증가함에 따라 트립닷컴은 더 높은 마진 성장을 보일 것으로 예상된다.
애널리스트들은 향후 12개월 동안 주가가 $56에서 $72 사이로 상승할 수 있으며, 평균 목표가가 $64로 예상하고 있다. 이는 인상적인 42.21%의 상승 잠재력을 나타낸다.
주가 움직임: 트립닷컴의 주식은 수요일 3.73% 하락한 $51.08에 마감되었다.
<h2 class="wp-block-heading">징둥닷컴: 전자상거래 지배력으로 37% 상승 기대</h2>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" class="wp-image-566104" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/25131748/Screenshot-2024-09-25-at-10.35.47-PM.png" sizes="(max-width: 681px) 100vw, 681px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/25131748/Screenshot-2024-09-25-at-10.35.47-PM.png 681w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/25131748/Screenshot-2024-09-25-at-10.35.47-PM-300x181.png 300w" alt="" width="681" height="412" /></figure>
출처: <a href="https://www.benzinga.com/report/JD" target="_blank" rel="noreferrer noopener">Benzinga 주식 보고서 &#8211; JD</a>
다음은 중국 최고의 전자상거래 플랫폼 중 하나인 징둥닷컴(NASDAQ:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/jd" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for JD">JD</a>)이다.
징둥닷컴(JD.com)의 강점은 광범위한 물류 및 이행 인프라에 있으며, 이는 올해 지금까지 22%의 상승을 이끌어냈다.
애널리스트들은 JD의 미래에 대해 낙관적이며, 주가가 $28에서 $47 사이로 예상되며, 평균 목표가가 $37.50로 제시하고 있다. 이는 향후 1년 동안 36.97%의 상승 잠재력을 시사하며, 또 다른 강력한 선택 종목으로 자리 잡고 있다.
주가 움직임: JD의 주식은 수요일 2.04% 하락한 $33.21에 마감되었다.
참고: <a href="https://www.benzinga.com//node/41005816">알리바바, AI 및 자율주행 진전을 위해 엔비디아와 파트너십 체결, 차트 긍정적 모멘텀 나타내어</a>
<h2 class="wp-block-heading">알리바바: 30% 상승을 노리는 전자 상거래 거인</h2>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" class="wp-image-566106" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/25131921/Screenshot-2024-09-25-at-10.35.27-PM.png" sizes="(max-width: 681px) 100vw, 681px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/25131921/Screenshot-2024-09-25-at-10.35.27-PM.png 681w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/25131921/Screenshot-2024-09-25-at-10.35.27-PM-300x181.png 300w" alt="" width="681" height="412" /></figure>
출처: <a href="https://www.benzinga.com/report/BABA" target="_blank" rel="noreferrer noopener">Benzinga 주식 보고서 &#8211; BABA</a>
마지막으로 소개할 종목은 글로벌 전자상거래 분야의 거대 기업인 알리바바 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABAF#NYSE">BABAF</a>)이 있다.
알리바바는 최근 몇 년 동안 어려움에 직면해 있지만 온라인 마켓플레이스에서 클라우드 컴퓨팅에 이르기까지 다양한 비즈니스 운영이 계속해서 분석가들의 관심을 끌고 있다. 주식은 올해 들어 21% 상승했으며, 애널리스트들은 12개월 가격 목표 범위를 $85에서 $130으로 예상하고 평균 $107.50로 제시하고 있다. 이는 29.78%의 상승 여력을 시사하며, 알리바바를 안정적인 장기 투자 종목으로 만들어 준다.
주가 움직임: 알리바바의 주식은 수요일 1.78% 하락한 $95.46에 마감되었다.

다음 읽기: 
<ul>
<li><a href="https://www.benzinga.com//node/41011343">중국의 부양책으로 기술 주식 상승, 자재 부문 상승, 엔비디아 급등: 시장을 움직이는 요인은?</a></li>
</ul>
사진 출처: Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Trip.com Group

뉴스

에 대한 최신 뉴스 Trip.com Group (NASDAQ:TCOM) 주식

목요일, 4월 10, 2025

일요일, 3월 09, 2025

화요일, 3월 04, 2025

일요일, 3월 02, 2025

화요일, 2월 25, 2025

일요일, 1월 05, 2025

월요일, 11월 18, 2024

일요일, 9월 29, 2024

목요일, 9월 26, 2024

화요일, 9월 03, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌